HIV News and Research

RSS

Scientists find certain species of nontuberculous mycobacteria in water that cause infection in humans

Brisbane's water supply has been found to contain disease carrying bugs which can be directly linked to infections in some patients, according to a new study by QUT.

3 Mar 2014

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

A new methodology for rapidly measuring the level of antibiotic drug molecules in human blood serum has been developed, paving the way to applications within drug development and personalised medicine.

3 Mar 2014

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Seattle BioMed today announced that Jason Beaubien, global health and development correspondent of National Public Radio (NPR), will deliver the keynote address at the Passport to Global Health Celebration on March 5.

28 Feb 2014

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

27 Feb 2014

Fred Hutchinson, SCCA researchers receive Seattle Business Magazine's 2014 Leaders in Health Care Awards

Researchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) were recognized in several categories of Seattle Business Magazine's 2014 Leaders in Health Care Awards, including the publication's Lifetime Achievement Award, given to Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutch and president of SCCA.

26 Feb 2014

Study: Rate of mother to child HIV transmission is at an all-time low in the UK

The rate of mother to child HIV transmission is at an all-time low in the UK, according to a paper published today in the journal AIDS.

26 Feb 2014

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Researchers from Case Western Reserve University have discovered how byproducts in the form of small fatty acids from two bacteria prevalent in gum disease incite the growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth.

26 Feb 2014

U.S study:10% of non-lifetime marijuana users report that they would try marijuana if legal

National support for marijuana ("cannabis") legalization is increasing in the United States (US). Recreational use was recently legalized in the states of Colorado and Washington; other states across the country are expected to follow suit.

26 Feb 2014

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.

25 Feb 2014

CBT improves blood sugar control and brings faster relief of depression in patients with type 2 diabetes

Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels.

25 Feb 2014

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

A selection of health policy stories from Minnesota, Texas, Louisiana, Florida, New York and Massachusetts.

24 Feb 2014

Social/behavioral intervention strategies may help drug users avoid injection-related HCV, HIV infections

Despite a number of social/behavioral intervention and educational programs, the spread of hepatitis C (HCV) in people who inject drugs (PWIDs) remains a chronic problem.

24 Feb 2014

First Edition: February 21, 2014

Today's headlines include reports checking the status of different state health exchanges as well as efforts to expand Medicaid.

21 Feb 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

Beta version of Cover Oregon gets mixed reviews

The troubled Cover Oregon insurance exchange unveiled its long-awaited beta website to mixed reviews Tuesday. Meanwhile, Humana announced it will waive fees for enrollees who bought plans on the Mississippi exchange who see a doctor by the end of June for a non-preventive visit. Also, Republicans probe state websites which are still having major problems.

19 Feb 2014

Researchers reveal effectiveness of web-based weight-loss programs

Researchers from The Miriam Hospital have found that DietBet, a web-based commercial weight loss program that pairs financial incentives with social influence, delivers significant weight losses. The study and its findings have been published in the current issue of the open access publication JMIR Serious Games.

19 Feb 2014

Chronic intake of marijuana protects critical immune tissue from damaging effects of HIV infection

New evidence that chronic intake of THC, the primary psychoactive ingredient in marijuana, can protect critical immune tissue in the gut from the damaging effects of HIV infection is reported in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

19 Feb 2014

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).

19 Feb 2014

New study explores the effect of food insecurity on treating HIV-infected pregnant women in Uganda

In Uganda the prescription of three antiretroviral (ARV) drugs, which aim to suppress the virus to prevent disease progression, have resulted in huge reductions in HIV mortality rates. However, disease is not the only scourge in Uganda, and a new study in The Journal of Clinical Pharmacology explores the impact food insecurity may have on treating pregnant women.

18 Feb 2014

New research may provide insight on how dengue virus gains entry into cells

Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever.

18 Feb 2014

HIV News and Research

Scientists find certain species of nontuberculous mycobacteria in water that cause infection in humans

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

Fred Hutchinson, SCCA researchers receive Seattle Business Magazine's 2014 Leaders in Health Care Awards

Study: Rate of mother to child HIV transmission is at an all-time low in the UK

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

U.S study:10% of non-lifetime marijuana users report that they would try marijuana if legal

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

CBT improves blood sugar control and brings faster relief of depression in patients with type 2 diabetes

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

Social/behavioral intervention strategies may help drug users avoid injection-related HCV, HIV infections

First Edition: February 21, 2014

Professor receives $17M NIH grant to support IMPAACT Network

Beta version of Cover Oregon gets mixed reviews

Researchers reveal effectiveness of web-based weight-loss programs

Chronic intake of marijuana protects critical immune tissue from damaging effects of HIV infection

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

New study explores the effect of food insecurity on treating HIV-infected pregnant women in Uganda

New research may provide insight on how dengue virus gains entry into cells

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News